Remove Disease Remove MRI Remove Pharmaceutical
article thumbnail

How AI is Transforming the Pharmaceutical Industry

MRI Network

It’s also primed to revolutionize the pharmaceutical industry. Pharma companies that truly embrace AI can run parallel clinical trials for the same drug as a single agent or in combinations targeting multiple diseases where the drug is predicted to work. Many pharma companies have changed their CEOs at least once.

article thumbnail

AuntMinnie 2017: Pull linear MRI contrast from market, European group says

AuntMinnie

In a stunning development, a European Union regulatory body on March 10 recommended that four gadolinium-based contrast agents (GBCAs) for MRI scans be pulled off the market due to concerns about gadolinium remaining in the body years after scans occur.

MRI 147
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Meilleur Technologies Inc. Announces Use of the Next-Generation Amyloid PET Imaging Biomarker, NAV-4694, in the Alzheimer’s Disease Neuroimaging Initiative 4 (ADNI4)

Imaging Technology

announced a research collaboration agreement with the Alzheimer’s Disease Neuroimaging Initiative 4, ADNI4, on the use of Meilleur’s [F-18]NAV-4694, an investigational imaging agent, in Positron Emission Tomography (PET) scans to assess the status amyloid plaque in the brain.

Disease 105
article thumbnail

Immunis Partners with Springbok Analytics on MRI-based AI Muscle Analysis Technology

Imaging Technology

a clinical-stage biotech developing groundbreaking secretome therapeutics for age and disease-related immune dysfunction, has announced a partnership with Springbok Analytics , a life sciences muscle analytics company. Springbok has developed the first commercialized technology to accurately quantify individual muscles from a rapid MRI.

MRI 104
article thumbnail

New CT, MR scanners and AI top GE HealthCare highlights at RSNA 2023

AuntMinnie

CHICAGO -- GE HealthCare (GEHC) brought new CT and MRI scanners and a range of AI software applications to McCormick Place for RSNA 2023. MRI GEHC unveiled Signa Champion, a 1.5-tesla, Pharmaceutical diagnostics The company pointed to a recent study that validated the use of AI models for predicting patient response to therapy.

article thumbnail

Bracco Imaging Announces Publication of Data Reinforcing Efficacy, Safety of Gadopiclenol in Contrast-Enhanced MRI of Certain Body Regions

Imaging Technology

mmol/kg gadobutrol (Gadavist) focused on adult patients referred for contrast-enhanced MRI of certain body regions. Of note, gadopiclenol was approved for both MRI of the central nervous system and of the body at the dose of 0.05 This multinational, crossover (within-patient), double-blind comparison of the safety and efficacy of 0.05

MRI 98
article thumbnail

GE HealthCare Closes MIM Software Acquisition

Imaging Technology

announced the acquisition’s close and addition of MIM Software’s imaging analytics and digital workflow solutions as a part of its leading global medical technology, pharmaceutical diagnostics, and digital portfolio. Together, we'll strive to continue our shared legacy of enhancing patient care.